- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ruxolitinib
Total 381 results
-
Brian DrukerAbbVie; Oregon Health and Science University; Incyte CorporationActive, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsAvailable
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
Massachusetts General HospitalIncyte CorporationActive, not recruitingMyelofibrosisUnited States
-
Massachusetts General HospitalIncyte CorporationActive, not recruiting
-
Constellation PharmaceuticalsThe Leukemia and Lymphoma SocietyActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Leukemia | Preleukemia | Primary Myelofibrosis | Myeloproliferative Disorders | Myelofibrosis | Precancerous Conditions | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic Syndrome (MDS) | Leukemia, Myelocytic, Acute | Bone Marrow Disease | Hematological Disease and other conditionsCanada, United States, United Kingdom, Germany, Italy, Belgium, France, Netherlands, Poland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
St. Jude Children's Research HospitalIncyte Corporation; Amgen; ServierActive, not recruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic LymphomaUnited States, Australia
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
Novartis PharmaceuticalsAvailablePrimary Myelofibrosis (PMF) | Polycythemia Vera (PV) | Post Polycythemia Myelofibrosis (PPV MF) | Thrombocythemia Myelofibrosis (PET-MF) | Severe/Very Severe COVID-19 Illness | Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD) | Steroid Refractory Chronic Graft Versus Host Disease...
-
Incyte CorporationCompletedVitiligoUnited States, Canada
-
Actuate Therapeutics Inc.Completed
-
Columbia UniversityIncyte CorporationActive, not recruitingAdvanced Cutaneous Squamous Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Bone | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
MacroGenicsTerminatedAMLUnited States, United Kingdom, Germany, Israel, Spain, France, Italy, Netherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
RWTH Aachen UniversityNovartis PharmaceuticalsActive, not recruitingPolycythemia Vera (PV) | Essential Thrombocythemia (ET)Germany
-
Incyte CorporationCompletedLichen SclerosusUnited States, Canada
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Adenocarcinoma | Recurrent Endometrial Carcinoma | Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Mixed Cell Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated... and other conditionsUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedSolid Organ Transplant | Acute-graft-versus-host Disease | Chronic Graft-versus-host-diseaseUnited States
-
Incyte CorporationChildren's Oncology GroupActive, not recruitingLeukemiaUnited States, Canada, Puerto Rico
-
University of RochesterIncyte CorporationActive, not recruiting
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada
-
Washington University School of MedicineRigel PharmaceuticalsTerminatedMyelofibrosis | ThrombocytopeniaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
University Health Network, TorontoActive, not recruiting
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
Chinese PLA General HospitalThe Second Hospital of Hebei Medical University; Air Force Military Medical... and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Masonic Cancer Center, University of MinnesotaIncyte CorporationCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloid and Monocytic LeukemiaUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Incyte CorporationCompleted
-
John MascarenhasCompleted
-
Incyte CorporationActive, not recruitingBreast Cancer | Pancreatic Cancer | Lung Cancer | Colorectal Cancer (CRC)United States
-
University of California, San FranciscoIncyte CorporationCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedAdherence, Patient | Adherence, TreatmentItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or AnemiaAnemia | Myelofibrosis | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Incyte CorporationCompletedAtopic DermatitisUnited States
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin LymphomaUnited States
-
University of NebraskaCompletedGraft-versus-host-disease (GVHD)United States
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Argentina, Australia, Brazil, Bulgaria, Chile, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Sweden, Turkey
-
Incyte CorporationCompletedAtopic DermatitisUnited States, France, Canada, Hungary, Poland, Germany, Italy
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Germany, Spain, Canada, Poland, Czechia, Bulgaria
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisGermany